- Home
- ZGM vs IGC Comparison
ZGM vs IGC Comparison
Compare ZGM & IGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZGM
- IGC
- Stock Information
- Founded
- ZGM N/A
- IGC 2005
- Country
- ZGM Macau
- IGC United States
- Employees
- ZGM N/A
- IGC N/A
- Industry
- ZGM Professional Services
- IGC Biotechnology: Pharmaceutical Preparations
- Sector
- ZGM Consumer Discretionary
- IGC Health Care
- Exchange
- ZGM Nasdaq
- IGC Nasdaq
- Market Cap
- ZGM 47.4M
- IGC 39.8M
- IPO Year
- ZGM 2025
- IGC N/A
- Fundamental
- Price
- ZGM N/A
- IGC $0.41
- Analyst Decision
- ZGM
- IGC Strong Buy
- Analyst Count
- ZGM 0
- IGC 2
- Target Price
- ZGM N/A
- IGC $4.00
- AVG Volume (30 Days)
- ZGM N/A
- IGC 1.4M
- Earning Date
- ZGM N/A
- IGC 11-11-2025
- Dividend Yield
- ZGM N/A
- IGC N/A
- EPS Growth
- ZGM N/A
- IGC N/A
- EPS
- ZGM N/A
- IGC N/A
- Revenue
- ZGM N/A
- IGC $1,327,000.00
- Revenue This Year
- ZGM N/A
- IGC $15.26
- Revenue Next Year
- ZGM N/A
- IGC $3.41
- P/E Ratio
- ZGM N/A
- IGC N/A
- Revenue Growth
- ZGM N/A
- IGC 24.95
- 52 Week Low
- ZGM N/A
- IGC $0.25
- 52 Week High
- ZGM N/A
- IGC $0.50
- Technical
- Relative Strength Index (RSI)
- ZGM N/A
- IGC 52.22
- Support Level
- ZGM N/A
- IGC $0.38
- Resistance Level
- ZGM N/A
- IGC $0.47
- Average True Range (ATR)
- ZGM 0.00
- IGC 0.04
- MACD
- ZGM 0.00
- IGC -0.00
- Stochastic Oscillator
- ZGM 0.00
- IGC 32.79
About IGC IGC Pharma Inc.
IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.